Skip to menu Skip to content Skip to footer
Dr Kai Lim
Dr

Kai Lim

Email: 

Overview

Availability

Dr Kai Lim is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Doctor of Philosophy of Microbiology, Queensland University of Technology

Works

Search Professor Kai Lim’s works on UQ eSpace

35 works between 2015 and 2026

1 - 20 of 35 works

2026

Journal Article

582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI

Shah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI. Gastrointestinal Endoscopy, 103 (5), S-2414. doi: 10.1016/s0016-5107(26)05633-6

582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI

2026

Journal Article

Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION

Fairlie, Thomas, Celine, Patricia, Shah, Ayesha, Lim, Yenkai, Morrison, Mark and Holtmann, Gerald (2026). Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION. Gastroenterology, 170 (6), S-2457. doi: 10.1016/s0016-5085(26)05814-2

Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION

2026

Journal Article

Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE

Shah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE. Gastrointestinal Endoscopy, 103 (5), S-2458. doi: 10.1016/s0016-5107(26)05746-9

Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE

2026

Journal Article

Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE

Shah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE. Gastroenterology, 170 (6), S-2458. doi: 10.1016/s0016-5085(26)05815-4

Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE

2026

Journal Article

582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI

Shah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI. Gastroenterology, 170 (6), S-2414. doi: 10.1016/s0016-5085(26)05702-1

582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI

2026

Journal Article

Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION

Fairlie, Thomas, Celine, Patricia, Shah, Ayesha, Lim, Yenkai, Morrison, Mark and Holtmann, Gerald (2026). Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION. Gastrointestinal Endoscopy, 103 (5), S-2457. doi: 10.1016/s0016-5107(26)05745-7

Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION

2025

Journal Article

Pro-inflammatory macrophages transporting gut-derived bacterial DNA drive autoimmune arthritis in spondyloarthropathy

Cai, Benjamin, Giri, Rabina, Cameron, Amy J., Rahman, M. Arifur, Small, Annabelle, Altmann, Christopher, Lim, Yenkai, Rehaume, Linda M., Morrison, Mark, Wechalekar, Mihir D., Begun, Jakob, Bergot, Anne-Sophie and Thomas, Ranjeny (2025). Pro-inflammatory macrophages transporting gut-derived bacterial DNA drive autoimmune arthritis in spondyloarthropathy. JCI Insight, 10 (17) e188028, 1-19. doi: 10.1172/jci.insight.188028

Pro-inflammatory macrophages transporting gut-derived bacterial DNA drive autoimmune arthritis in spondyloarthropathy

2025

Conference Publication

Exploring the link between duodenal microbial dysbiosis, immune regulation, and clinical symptoms in gastroparesis

Moniruzzaman, Md, Shah, Ayesha, Lim, Yenkai, Fairlie, Thomas, Do, Anh, Morrison, Mark, Koloski, Natasha and Holtmann, Gerald J. (2025). Exploring the link between duodenal microbial dysbiosis, immune regulation, and clinical symptoms in gastroparesis. Digestive Disease Week 2025 (DDW2025), San Diego, CA, United States and online, 3-6 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(25)04239-8

Exploring the link between duodenal microbial dysbiosis, immune regulation, and clinical symptoms in gastroparesis

2025

Conference Publication

Gut microbiome signatures discriminate nontuberculous mycobacterial pulmonary disease patients requiring treatment from those with stable disease

Thompson, R., Lim, Y., Goh, F., Blumenthal, A., Morrison, M. and Thomson, R. (2025). Gut microbiome signatures discriminate nontuberculous mycobacterial pulmonary disease patients requiring treatment from those with stable disease. ATS 2025 International Conference, San Francisco, CA USA, 16-21 May 2025. New York, NY USA: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.Abstracts.A3175

Gut microbiome signatures discriminate nontuberculous mycobacterial pulmonary disease patients requiring treatment from those with stable disease

2025

Journal Article

Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?

Lim, Yenkai, Kang, Seungha, Shah, Ayesha, Holtmann, Gerald and Morrison, Mark (2025). Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?. Gut, 74 (4), 692-693. doi: 10.1136/gutjnl-2024-334069

Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?

2024

Conference Publication

Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa

Fairlie, Thomas, Shah, Ayesha, Lim, Yenkai, Teh, Jing-Jie, Schooth, Lauren, Morrison, Mark and Holtmann, Gerald (2024). Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa

2024

Journal Article

Maternal high fat diet induces circadian clock-independent endocrine alterations impacting the metabolism of the offspring

Ding, Lu, Weger, Benjamin D., Liu, Jieying, Zhou, Liyuan, Lim, Yenkai, Wang, Dongmei, Xie, Ziyan, Liu, Jing, Ren, Jing, Zheng, Jia, Zhang, Qian, Yu, Miao, Weger, Meltem, Morrison, Mark, Xiao, Xinhua and Gachon, Frédéric (2024). Maternal high fat diet induces circadian clock-independent endocrine alterations impacting the metabolism of the offspring. iScience, 27 (7) 110343, 110343. doi: 10.1016/j.isci.2024.110343

Maternal high fat diet induces circadian clock-independent endocrine alterations impacting the metabolism of the offspring

2024

Conference Publication

Simethicone Suppresses The Growth Of Microbes Cultured From The Human Duodenal Mucosa

Fairlie, Thomas, Shah, Ayesha, Lim, Yenkai, Teh, Jing Jie, Schooth, Lauren F., Morrison, Mark and Holtmann, Gerald J. (2024). Simethicone Suppresses The Growth Of Microbes Cultured From The Human Duodenal Mucosa. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02466-1

Simethicone Suppresses The Growth Of Microbes Cultured From The Human Duodenal Mucosa

2024

Conference Publication

A Novel Isolate Of Streptococcus Salivarius, AGIRA0003, Disrupts Tight Junctions Ex Vivo In Functional Dyspepsia

Burns, Grace L., Wark, Jasmine A., Hoedt, Emily C., Minahan, Kyra, Sherwin, Simonne, Bruce, Jessica K., Lim, Yenkai, Teh, Jing Jie, Jamaluddin, M. Fairuz, Soh, Wai Sinn, Caban, Shandelle, Almazi, Juhura, Woldu, Ameha S., Dun, Matthew D., Potter, Michael D., Shanahan, Erin R., Holtmann, Gerald J., Walker, Marjorie M., Morrison, Mark, Talley, Nicholas J. and Keely, Simon (2024). A Novel Isolate Of Streptococcus Salivarius, AGIRA0003, Disrupts Tight Junctions Ex Vivo In Functional Dyspepsia. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02260-1

A Novel Isolate Of Streptococcus Salivarius, AGIRA0003, Disrupts Tight Junctions Ex Vivo In Functional Dyspepsia

2024

Conference Publication

The Duodenal Mucosa-associated Microbiota Of Patients With A Disorder Of Gut-brain Interaction Can Be Differentiated By Rome IV Criteria

Schooth, Lauren F., Kang, Seungha, Fairlie, Thomas, Lim, Yenkai, Teh, Jing Jie, Hoedt, Emily C., Keely, Simon, Shah, Ayesha, Holtmann, Gerald J. and Morrison, Mark (2024). The Duodenal Mucosa-associated Microbiota Of Patients With A Disorder Of Gut-brain Interaction Can Be Differentiated By Rome IV Criteria. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02266-2

The Duodenal Mucosa-associated Microbiota Of Patients With A Disorder Of Gut-brain Interaction Can Be Differentiated By Rome IV Criteria

2023

Conference Publication

The interplay of IL-23, probiotic and pathobiont bacteria in the pathogenesis of ileitis and spondyloarthritis in the SKG mouse model

Bergot, Anne-Sophie, Cai, Benjamin, Giri, Rabina, Cameron, Amy, Duggan, Emily, Lim, Kai, Rehaume, Linda, Morrison, Mark, Begun, Jakob and Thomas, Ranjeny (2023). The interplay of IL-23, probiotic and pathobiont bacteria in the pathogenesis of ileitis and spondyloarthritis in the SKG mouse model. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Hoboken, NJ, United States: Wiley.

The interplay of IL-23, probiotic and pathobiont bacteria in the pathogenesis of ileitis and spondyloarthritis in the SKG mouse model

2022

Conference Publication

Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms

Schooth, L., Sid-Ahmed, A., Kang, S., Lim, Y., Fairlie, T., Shah, A., Holtmann, G. and Morrison, M. (2022). Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC, Australia: John Wiley & Sons.

Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms

2022

Conference Publication

Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing

Schooth, Lauren F., Ahmed, Ahmed Sid, Kang, Seungha, Shah, Ayesha, Fairlie, Thomas, Teh, Jing Jie, Lim, Yenkai, Hoedt, Emily C., Talley, Nicholas J., Keely, Simon, Holtmann, Gerald J. and Morrison, Mark (2022). Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)61208-3

Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing

2021

Journal Article

The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer

Banavar, Guruduth, Ogundijo, Oyetunji, Toma, Ryan, Rajagopal, Sathyapriya, Lim, Yen Kai, Tang, Kai, Camacho, Francine, Torres, Pedro J., Gline, Stephanie, Parks, Matthew, Kenny, Liz, Perlina, Ally, Tily, Hal, Dimitrova, Nevenka, Amar, Salomon, Vuyisich, Momchilo and Punyadeera, Chamindie (2021). The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer. npj Genomic Medicine, 6 (1) 105, 105. doi: 10.1038/s41525-021-00257-x

The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer

2021

Conference Publication

Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing

Schooth, L., Kang, S., Lim, Y., Shah, A., Fairlie, T., Jimenez-Loayza, J., Teh, J.-J., Holtmann, G. and Morrison, M. (2021). Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing. GESA AGW 2021, Online, 4-12 September 2021. Richmond, VIC Australia: Wiley-Blackwell.

Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing

Funding

Current funding

  • 2025 - 2026
    Metabolomic signatures of the duodenal mucosa associated microbiota in Primary Sclerosing Cholangitis (PSC) and its associated Inflammatory Bowel Disease (IBD)
    University of Newcastle
    Open grant

Supervision

Availability

Dr Kai Lim is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Kai Lim's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au